Lijie Wang
- Oncology top 10%
- Infectious Diseases top 5%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Topics
- Cancer Immunotherapy and Biomarkers (10 papers)Lung Cancer Treatments and Mutations (9 papers)Lung Cancer Research Studies (8 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lijie Wang
69 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 122
- Oncology 350
- Infectious Diseases 268
- Pulmonary and Respiratory Medicine 230
- Molecular Biology 212
- Radiology, Nuclear Medicine and Imaging 210
Countries citing papers authored by Lijie Wang
This map shows the geographic impact of Lijie Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijie Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijie Wang more than expected).
Fields of papers citing papers by Lijie Wang
This network shows the impact of papers produced by Lijie Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijie Wang. The network helps show where Lijie Wang may publish in the future.
Co-authorship network of co-authors of Lijie Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Lijie Wang. A scholar is included among the top collaborators of Lijie Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijie Wang. Lijie Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 14 | |
| 9 | 3 | |
| 10 | 34 | |
| 11 | 64 | |
| 12 | 34 | |
| 13 | 18 | |
| 14 | 33 | |
| 15 | Clinical analysis of 14 cases of community-acquired Pseudomonas aeruginosa bacteraemia in children | 1 |
| 16 | 6 | |
| 17 | [Evaluation on clinical effect of long-term shexiang baoxin pill administration for treatment of coronary heart disease]. | 15 |
| 18 | 20 | |
| 19 | 15 | |
| 20 | 34 |
About Lijie Wang
Lijie Wang is a scholar working on Oncology, Internal Medicine and Pulmonary and Respiratory Medicine, having authored 79 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Lung Cancer Research Studies (8 papers). The work is most often cited by research in Infectious Diseases (268 citations), Oncology (350 citations) and Radiology, Nuclear Medicine and Imaging (210 citations). Lijie Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Rongbao Gao, Dahai Zhao, Feifei Yao, Yongjun Gao, Feng Guo, Hui Zhao, Jun Ye, Ling Zheng, Yan Sun and Yi Hu. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.